Scientific corner

Granulomonocytapheresis as a cell-dependent treatment option for patients with inflammatory bowel disease: Concepts and clinical features for better therapeutic outcomes.

Abbi R Saniabadi 1Tomotaka Tanaka 2Takayuki Yamamoto 3Wolfgang Kruis 4Rodolfo Sacco 5 , J Clin Apher 2019 Feb;34(1):51-60. 

Accordingly, for responder patients, GMA fulfills a desire to be treated without drugs.

https://pubmed.ncbi.nlm.nih.gov/30407662/

Contact UsFor more information

Contact Us